Fig. 3

Unadjusted and adjusted HRs and 95% CIs for the primary end point (all-cause mortality) of diabetes and prediabetes Model 1: unadjusted; Model 2: adjusted for age and gender; Model 3: adjusted for age, gender, triglycerides, low-density lipoprotein cholesterol, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, calcium channel blocker, uremic acid, estimated glomerular filtration rate, systolic blood pressure, history of smoking, and comorbidities including chronic kidney disease, congestive heart failure, coronary artery disease, acute myocardial infarction, percutaneous coronary intervention